Schonfeld Strategic Advisors LLC Acquires 10,327 Shares of BrightSpring Health Services, Inc. (NASDAQ:BTSG)

Schonfeld Strategic Advisors LLC increased its holdings in shares of BrightSpring Health Services, Inc. (NASDAQ:BTSG) by 30.3% during the 4th quarter, HoldingsChannel reports. The firm owned 44,400 shares of the company’s stock after purchasing an additional 10,327 shares during the period. Schonfeld Strategic Advisors LLC’s holdings in BrightSpring Health Services were worth $756,000 as of its most recent SEC filing.

Other institutional investors have also modified their holdings of the company. JPMorgan Chase & Co. raised its holdings in BrightSpring Health Services by 275.2% during the 3rd quarter. JPMorgan Chase & Co. now owns 163,618 shares of the company’s stock worth $2,402,000 after buying an additional 120,005 shares during the period. Legato Capital Management LLC raised its holdings in shares of BrightSpring Health Services by 40.0% during the fourth quarter. Legato Capital Management LLC now owns 66,910 shares of the company’s stock worth $1,139,000 after acquiring an additional 19,120 shares during the period. SG Americas Securities LLC lifted its position in BrightSpring Health Services by 50.9% in the 4th quarter. SG Americas Securities LLC now owns 37,000 shares of the company’s stock valued at $630,000 after acquiring an additional 12,486 shares in the last quarter. Barclays PLC lifted its position in BrightSpring Health Services by 22.2% in the 3rd quarter. Barclays PLC now owns 393,725 shares of the company’s stock valued at $5,780,000 after acquiring an additional 71,633 shares in the last quarter. Finally, Raymond James Financial Inc. acquired a new position in BrightSpring Health Services in the 4th quarter worth $18,257,000.

Analyst Ratings Changes

Several analysts have issued reports on the company. UBS Group lifted their price target on BrightSpring Health Services from $22.00 to $30.00 and gave the company a “buy” rating in a research note on Wednesday, January 29th. Mizuho set a $26.00 target price on BrightSpring Health Services in a research report on Monday. One research analyst has rated the stock with a hold rating and nine have assigned a buy rating to the company’s stock. According to data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average target price of $22.33.

BrightSpring Health Services Price Performance

NASDAQ:BTSG opened at $22.52 on Friday. BrightSpring Health Services, Inc. has a 52-week low of $10.15 and a 52-week high of $24.82. The company has a market cap of $3.94 billion, a P/E ratio of -86.60 and a beta of 2.06. The company has a debt-to-equity ratio of 1.63, a quick ratio of 0.97 and a current ratio of 1.35. The stock’s 50-day simple moving average is $17.87 and its 200 day simple moving average is $18.65.

BrightSpring Health Services (NASDAQ:BTSG) last announced its quarterly earnings data on Friday, May 2nd. The company reported $0.19 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.09 by $0.10. The company had revenue of $2.88 billion for the quarter, compared to analysts’ expectations of $2.74 billion. BrightSpring Health Services had a positive return on equity of 4.16% and a negative net margin of 0.38%. The business’s revenue was up 25.9% compared to the same quarter last year. During the same quarter in the prior year, the business posted $0.12 EPS. As a group, sell-side analysts forecast that BrightSpring Health Services, Inc. will post 0.59 EPS for the current fiscal year.

BrightSpring Health Services Profile

BrightSpring Health Services, Inc operates a home and community-based healthcare services platform in the United States. The company's platform focuses on delivering pharmacy and provider services, including clinical and supportive care in home and community settings to Medicare, Medicaid, and insured populations.